Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Jay Knight Provides Insight on How Companies Can Participate in the Regulatory Rulemaking Process

Media Mentions

July 29, 2015

Bass, Berry & Sims attorney Jay Knight was quoted extensively in the book, Financial Regulation and Compliance, suggesting how a company can participate in the federal regulatory rulemaking process. Jay, drawing on his experience as a former attorney with the SEC's Division of Corporation Finance, recommends that a company participate in the comment letter process to voice ideas and concerns related to proposed rules. According to Jay, "he has often seen changes in the final rule based on the comments made by the public, and notes that, particularly at the SEC, there will be extensive footnotes in the SEC's final rules citing to comment letters, and indicating that the revision made often reflects the view that a majority of the commenters expressed."

Jay is quoted throughout the chapter, "How to Participate in the Regulatory Comment Process," in the book Financial Regulation and Compliance: How to Manage Competing and Overlapping Regulatory Oversight (Copyright 2015). The book was written by H. David Kotz, Managing Director at Berkeley Research Group an international expert services and consulting firm and previously the Inspector General at the SEC, and provides compliance professionals with a one-stop resource for navigating the numerous regulations that have been enacted in response to the financial crisis. Information about Financial Regulation and Compliance is available on the Wiley Finance Series website.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.